To identify new genetic risk factors for rheumatoid arthritis, we conducted a genome-wide
association study meta-analysis of 5,539 autoantibody-positive individuals with rheumatoid …

To discover new rheumatoid arthritis (RA) risk loci, we systematically examined 370 SNPs
from 179 independent loci with P < 0.001 in a published meta-analysis of RA genome-wide …

Recent evidence suggests a role for natural killer (NK) cells in the control of multiple myeloma.
We show that expression of the NK cell receptor DNAM-1 (CD226) is reduced on CD56 …

Copy number (CN) variation (CNV) has been shown to be common in regions of the genome
coding for immune-related genes, and thus impacts upon polygenic autoimmunity. Low CN …

Background Glucocorticoids are widely used to reduce disease activity and inflammation in
patients with a range of immune-mediated inflammatory diseases. It is uncertain whether or …

Psoriatic arthritis (PsA) is a chronic inflammatory arthritis associated with psoriasis and,
despite the larger estimated heritability for PsA, the majority of genetic susceptibility loci …

Background The NLRP3-inflammasome, implicated in the pathogenesis of several
inflammatory disorders, has been analysed in rheumatoid arthritis (RA). Methods Relative gene …

Importance Advances have been made in identifying genetic susceptibility loci for
autoimmune diseases, but evidence is needed regarding their association with prognosis and …

Rheumatoid arthritis (RA) is a chronic, inflammatory disease of the synovium of uncertain
pathogenesis. A number of phenotypic and functional T-cell defects have been described in RA…

Anti-tumor necrosis factor alpha (anti-TNF) biologic therapy is a widely used treatment for
rheumatoid arthritis (RA). It is unknown why some RA patients fail to respond adequately to anti…